Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets close in 1 hr 6 mins

S&P 500
5,850.62
-3.36(-0.06%)
Dow 30
42,951.74
+20.14(+0.05%)
Nasdaq
18,563.78
+23.77(+0.13%)
Russell 2000
2,234.20
-5.51(-0.25%)
Crude Oil
72.24
+1.68(+2.38%)
Gold
2,759.80
+20.90(+0.76%)

Taiko Pharmaceutical Co.,Ltd. (4574.T)

Tokyo - Tokyo Delayed Price. Currency in JPY

Follow

385.00

-4.00

(-1.03%)

At close: 03:15PM JST

Currency in JPY

Valuation Measures⁴

Market Cap (intraday)	19.53B
Enterprise Value	16.98B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	3.01
Price/Book (mrq)	2.42
Enterprise Value/Revenue	2.61
Enterprise Value/EBITDA	-1.72

Trading Information

Stock Price History

Beta (5Y Monthly)	0.15
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	495.00
52 Week Low ³	263.00
50-Day Moving Average ³	405.74
200-Day Moving Average ³	376.56

Share Statistics

Avg Vol (3 month) ³	174.86k
Avg Vol (10 day) ³	104.15k
Shares Outstanding ⁵	50.19M
Implied Shares Outstanding ⁶	N/A
Float ⁸	31.37M
% Held by Insiders ¹	42.85%
% Held by Institutions ¹	7.56%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	1.04
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	Dec 29, 2021
Last Split Factor ²	3:1
Last Split Date ³	Mar 30, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-35.94%
Operating Margin (ttm)	18.07%

Management Effectiveness

Return on Assets (ttm)	-0.55%
Return on Equity (ttm)	-27.05%

Income Statement

Revenue (ttm)	6.49B
Revenue Per Share (ttm)	130.40
Quarterly Revenue Growth (yoy)	12.30%
Gross Profit (ttm)	N/A
EBITDA	354M
Net Income Avi to Common (ttm)	-2.33B
Diluted EPS (ttm)	-49.64
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	5.15B
Total Cash Per Share (mrq)	102.64
Total Debt (mrq)	2.6B
Total Debt/Equity (mrq)	32.23
Current Ratio (mrq)	3.61
Book Value Per Share (mrq)	160.84

Cash Flow Statement

Operating Cash Flow (ttm)	-177M
Levered Free Cash Flow (ttm)	-452.38M